Keeping it Simple Study (KISS) (KISS)

December 24, 2024 updated by: Bettina Eiger

Keeping It Simple Study (KISS) - Pain Science Education for Patients With Chronic Musculoskeletal Pain Undergoing Community-based Rehabilitation: A Multicenter Randomized Controlled Trial

Problem: The number of patients living with chronic musculoskeletal (MSK) pain has steadily increased over the past decade with costs rising equally. Long-standing pain is associated with significant maladaptive beliefs about pain, psychological characteristics and associated behaviors which involve structural and functional neurobiological characteristics which share common pathophysiological mechanisms as chronic pain. The investigators recent priority setting partnership investigated the research priorities from 1000 patients with chronic MSK pain, relatives, and clinicians. Better pain education was rated as one of the three most important research areas.

Solution: Pain science education has the potential to target maladaptive psychological and behavioral components that may contribute to the maintenance of chronic pain. The KISS project will evaluate the effect of a pain neuroscience education program (PNE4Adults) on rehabilitation outcomes in patients with chronic MSK pain. This intervention has the potential to change beliefs and behaviors surrounding pain in patients with chronic MSK pain. If this is successful in disrupting maladaptive cycles contributing to chronicity, this may improve outcomes for many thousand citizens.

Study Overview

Detailed Description

Introduction: Between 20% and 33% of people across the globe live with a painful musculoskeletal (MSK) condition. Costs correspond to almost 2% of the gross domestic products of European countries, posing a challenge for health care systems across the world. Patients with chronic musculoskeletal pain have a high use of healthcare, reduced work ability, loss of productivity, and loss of quality of life. Current care guidelines underline that pain science education (PSE) is a vital part of the care delivered to people suffering from chronic pain. PSE is thought in part to attenuate central sensitization and improve self-efficacy potentially mediated through decreased pain catastrophizing and modulating nocebo-related effects. On a patient level, PSE has been shown to reduce pain catastrophizing, pain intensity, and fear-avoidance in addition to improved physical functioning, self-efficacy, and pain knowledge. Combining exercise and PSE shows greater short-term improvements in pain, disability, kinesiophobia, and pain catastrophizing compared to exercise alone and the RESTORE-trial showed the benefit of adding cognitive components. On a societal level, PSE has further shown to minimize health expenses. However, some of the proposed barriers include training of the therapist delivering the education, access to training material, time during consultation, and patients' health literacy levels. Even in Denmark, a country with a highly educated population, the prevalence of people with inadequate health literacy is high, with nearly 4 out of 10 people facing difficulties accessing, understanding, appraising, and applying health information. This underlines the need to consider novel ways of delivering PSE across all levels of health literacy.

Due to the lack of tools to facilitate PSE programs, the investigators adapted an existing pain science education program that was developed by Pas et al. (2018) (PNE4Kids) to teach children with chronic pain about the underlying biopsychosocial mechanisms contributing to pain. The adapted version, named PNE4Adults, consists of a manual for the therapist and a board game to enhance engagement and participant involvement. It provides the therapist with a clear "how-to" manual and an accessible way for patients to understand the complex concept of pain. This new PSE program may also hold promise for adult patients with low levels of health literacy and enhance learning due to its practical tools and build-in teach-back. The focus on integrating PSE into rehabilitation may enhance the therapeutic alliance needed to facilitate the patients' ability to manage their own symptoms. The investigators feasibility study in adult patients with chronic MSK pain in community-based rehabilitation (Eiger, Rathleff et al. 2024 - under review) showed that PNE4Adults was well accepted (100%) and understandable by all (100%) patients, including those with low levels of health literacy. Qualitive interviews revealed that patients (irrespective of their health literacy) acquired a deeper understanding of their own situation and their pain. This novel approach may reduce the inequality in delivering of pain education.

Purpose of Sub-project 1 The primary aim of the KISS-project is to evaluate the added effect of PSE ('PNE4Adults') to "usual care" compared to "usual care" alone in community-based rehabilitation.

The investigators hypothesis is PSE plus "usual care" will result in a larger improvement of musculoskeletal health (MSK-HQ) after 3 months (primary endpoint) compared to patients undergoing "usual care" in the municipality.

Purpose of Sub-project 2 The secondary aim is to use a process evaluation to understand how it works, and for whom the program works.

The purpose of the process evaluation is to understand how it worked and for whom, and not if it worked. The investigators will combine in-house registrations from the municipality, clinician observations, individual interviews, and focus-group interviews to answer what works for whom and under which circumstances. This will give the investigators additional insights into the novel PSE intervention, shedding light on how it induces change and uncovering any potential unintended consequences. This will support future implementation pending results.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Michael S. Rathleff, dr.med., PhD
  • Phone Number: +4522117002
  • Email: mirs@hst.aau.dk

Study Locations

    • Region Sjælland
      • Holbæk, Region Sjælland, Denmark, 4300
        • Recruiting
        • Træningsenheden, Holbæk Municipality
        • Contact:
          • Helle B. Hansen, PT
          • Phone Number: 72363252
          • Email: helha@holb.dk
      • Køge, Region Sjælland, Denmark, 4600
        • Recruiting
        • Træningsenheden, Køge Municipality
        • Contact:
      • Solrød Strand, Region Sjælland, Denmark, 2680
        • Recruiting
        • Genoptræningscenteret, Solrød Municipality
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients referred for rehabilitation in the municipalities Køge, Holbæk, and Solrød
  • With chronic (>3 months) musculoskeletal pain.
  • Adult patients (≥18 years) - no upper limit
  • Able to understand, speak, and write Danish.

Exclusion Criteria:

  • Known cognitive deficits (e.g., dementia).
  • Diagnosed with cancer or other serious pathologies, e.g., cauda equina.
  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids, or other drugs.
  • Neurologic or psychiatric diagnoses that hinder participation, e.g., stroke and borderline.
  • Lack of ability to cooperate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: "Usual care"
"Usual Care": The control group receives unrestricted "usual care". It could include a patient interview with individual goal setting and subsequent rehabilitation using cardio and strengthening exercises towards achieving the determined goals. It will be delivered by an authorized physiotherapist, and the intervention is determined by patient preferences, physiotherapist's clinical reasoning, and available resources.
Is formerly described under arm descriptions
Experimental: PNE4Adults - pain science education
PNE4Adults: In this group, the participants will receive an add-on individualized PSE in addition to the usual care with the PNE4Adults resource. The PNE4Adults session will follow the developed manual (http://www.paininmotion.be/pne4kids) and will be delivered by a physiotherapist in two sessions of each 30-45 minutes, shortly following the first meeting. Firstly, the function of a normal pain system is introduced, with examples of the pain being overly or under protective. Then, the patient teaches back giving the therapist the opportunity to evaluate the understanding and, if necessary, repeat essential key messages. Secondly, the sensitized pain system is explained. Thirdly, the subject is asked to reflect on this new information in relation to his/her own situation. Subsequently, the new knowledge is integrated in "usual care" with any additional measures that need to be included, e.g., graded exposure, stress relief, graded activity, and cognitive therapies.
Is formerly described under arm descriptions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Musculoskeletal Health Questionnaire (MSK-HQ)
Time Frame: Primary endpoint at 3 months, additional at 6 weeks and 6 months
Musculoskeletal (MSK) Health assessed by the Musculoskeletal Health Questionnaire. Score from 0 to 56. Higher scores reflect better MSK health, and better outcome
Primary endpoint at 3 months, additional at 6 weeks and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Pain intensity
Time Frame: At 6 weeks, 3 months and 6 months
Average of two numeric rating scales (most severe pain and average pain past 24 hours). Scores from 0 to 10. Higher scores reflect more intense pain, and worse outcome.
At 6 weeks, 3 months and 6 months
Pain interference
Time Frame: At 6 weeks, 3 months and 6 months
Pain interference subscale of Brief Pain Inventory, Score from 0 to 70, higher scores reflect more bothersome and worse outcomes.
At 6 weeks, 3 months and 6 months
Concept of pain
Time Frame: At 6 weeks, 3 months and 6 months
Measured on the Adult Concept of Pain Inventory, Danish. Scores from 0 to 52. Higher scores reflect more alignment with contemporary pain science knowledge and better outcome.
At 6 weeks, 3 months and 6 months
Pain catastrophizing
Time Frame: At 6 weeks, 3 months and 6 months
Measured on the Pain Catastrophizing Scale, Score from 0 to 52. Higher scores reflect worse outcomes
At 6 weeks, 3 months and 6 months
Fear of movement
Time Frame: At 6 weeks, 3 months and 6 months
Measured on the Tampa Scale of Kinesiophobia (TSK-11), scores between 11 and 44. Higher scores reflect more fear of movement and worse outcomes
At 6 weeks, 3 months and 6 months
Patient specific functional limitation
Time Frame: At 6 weeks, 3 months and 6 months
Patient-Specific Functional Scale, scores from 0 to 10. Higher scores reflect better outcomes
At 6 weeks, 3 months and 6 months
Patient impression of change
Time Frame: At 6 weeks, 3 months and 6 months
Global Impression of Change Scale (GISC), From "very much improved" to "very much worse".
At 6 weeks, 3 months and 6 months
Patient satisfaction with current symptom state
Time Frame: At 6 weeks, 3 months and 6 months
Measured with the Patient Acceptable Symptom State (PASS), Yes/No answer. No is worse outcome.
At 6 weeks, 3 months and 6 months
Pain Self-efficacy
Time Frame: At 6 weeks, 3 months and 6 months
Pain Self-efficacy Questionnaire (PSEQ), scores from 0 to 60, higher scores reflect higher self-efficacy and better outcome.
At 6 weeks, 3 months and 6 months
Adverse events
Time Frame: "through study completion, an average of 6 months".
Any adverse events will be noted. The higher the number, the worse outcome
"through study completion, an average of 6 months".

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Bettina Eiger, PhD-student, Aalborg University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

February 29, 2024

First Submitted That Met QC Criteria

March 6, 2024

First Posted (Actual)

March 7, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 24, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Usual care

Subscribe